Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 12, 2014, Pages

  Yamada, Shunsuke ^a,b   Tokumoto, Masanori ^b   Tatsumoto, Narihito ^a   Taniguchi, Masatomo ^a   Noguchi, Hideko ^a   Nakano, Toshiaki ^a   Masutani, Kosuke ^a   Ooboshi, Hiroaki ^b   Tsuruya, Kazuhiko ^a   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Chronic kidney disease; Inflammation; Malnutrition; Malnutrition inflammation atherosclerosis syndrome; Phosphate; Vascular calcification

Indexed keywords

ACUTE PHASE PROTEIN; ADENINE; ALBUMIN; BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; CALCIUM; CREATININE; FETUIN A; FIBROBLAST GROWTH FACTOR 23; LANTHANUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE; TRANSCRIPTION FACTOR PIT 1; TUMOR NECROSIS FACTOR ALPHA;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR MORTALITY; CELL CULTURE; CELL TRANSDIFFERENTIATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE SEVERITY; FOOD INTAKE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HYPERPHOSPHATEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; MALE; MALNUTRITION; NONHUMAN; OXIDATIVE STRESS; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RAT; SMOOTH MUSCLE FIBER; SYSTEMIC DISEASE; SYSTEMIC INFLAMMATION; TISSUE LEVEL; UREMIA; VASCULAR SMOOTH MUSCLE; VITAMIN BLOOD LEVEL; WEIGHT REDUCTION;

CHRONIC KIDNEY DISEASE; INFLAMMATION; MALNUTRITION; MALNUTRITION-INFLAMMATION-ATHEROSCLEROSIS SYNDROME; PHOSPHATE; VASCULAR CALCIFICATION;

ACUTE-PHASE PROTEINS; ADENINE; ANIMALS; BLOOD PRESSURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; HUMANS; INFLAMMATION; MALE; MALNUTRITION; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PHOSPHATES; RATS; RENAL INSUFFICIENCY, CHRONIC; TUMOR NECROSIS FACTOR-ALPHA; UREMIA; VASCULAR CALCIFICATION;

EID: 84902683100     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00633.2013     Document Type: Article

References (53)

1. Al-Aly Z. Phosphate, oxidative stress, and nuclear factor-κB activation in vascular calcification. Kidney Int 79: 1044-1047, 2011.
2. Atkinson J. Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. J Appl Physiol 105: 1643-1651, 2008.
3. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Lemke HD, Tribouilloy C, Choukroun G, Vanholder R, Massy ZA. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int 77: 550-556, 2010.
4. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004.
5. Cha MK, Kim IH. Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem Biophys Res Commun 222: 619-625, 1996.
6. Chaudhury C, Mehnaz S, Robinson JM, Hayton WL, Pearl DK, Roopenian DC, Anderson CL. The major histocompatibility complexrelated Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197: 315-322, 2003.
7. Darlington GJ, Wilson DR, Lachman LB. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 103: 787-793, 1986.
8. Dong W, Simeonova PP, Gallucci R, Matheson J, Fannin R, Montuschi P, Flood L, Luster MI. Cytokine expression in hepatocytes: role of oxidant stress. J Interferon Cytokine Res 18: 629-638, 1998.
9. Fleet M, Osman F, Komaragiri R, Fritz A, D. Protein catabolism in advanced renal disease: role of cytokines. Clin Nephrol 70: 91-100, 2008.
10. Guerrero F, Montes de Oca A, Aguilera-Tejero E, Zafra R, Rodríguez M, López I. The effect of vitamin D derivatives on vascular calcification associated with inflammation. Nephrol Dial Transplant 27: 2206-2212, 2012.
11. Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21: 1998-2007, 2010.
12. Hruska KA, Mathew S, Lund R, Qiu P, Pratt R. Hyperphosphatemia of chronic kidney disease. Kidney Int 74: 148-157, 2008.
13. Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M. Phosphate binders and survival on hemodialysis. J Am Soc Nephrol 20: 388-396, 2009.
14. Jahnen-Dechent W, Heiss A, Schäfer C, Ketteler M. Fetuin-A regulation of calcified matrix metabolism. Circ Res 108: 1494-1509, 2011.
15. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17, 2000.
16. Kakuta T, Tanaka R, Hyodo T, Suzuki H, Kanai G, Nagaoka M, Takahashi H, Hirawa N, Oogushi Y, Miyata T, Kobayashi H, Fukagawa M, Saito A. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients. Am J Kidney Dis 57: 422-431, 2011.
17. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-Inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42: 864-881, 2003.
18. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5: 519-530, 2010.
19. Kawata T, Nagano N, Obi M, Miyata S, Koyama C, Kobayashi N, Wakita S, Wada M. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int 74: 1270-1277, 2008.
20. Kim J, Bronson CL, Hayton WL, Radmacher MD, Roopenian DC, Robinson JM, Anderson CL. Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces. Am J Physiol Gastrointest Liver Physiol 290: G352-G360, 2006.
21. Kotur-Stevuljevic J, Simic-Ogrizovic S, Dopsaj V, Stefanovic A, Vujovic A, Ivanic-Corlomanovic T, Spasic S, Kalimanovska-Spasojevic V, Jelic-Ivanovic Z. A hazardous link between malnutrition, inflammation and oxidative stress in renal patients. Clin Biochem 45: 1202-1205, 2012.
22. Lee CT, Tsai YC, Ng HY, Su Y, Lee WC, Lee LC, Chiou TT, Liao SC, Hsu KT. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study. J Ren Nutr 19: 220-227, 2009.
23. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003.
24. Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y. Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenineinduced renal failure. Kidney Int 75: 915-928, 2009.
25. Mitch WE. Insight into the abnormalities of chronic renal disease attributed to malnutrition. J Am Soc Nephrol 13, Suppl 1: S22-S27, 2002.
26. Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, Liang Y, Radcliff JS, White KE, Gattone VH 2nd. A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 75: 176-184, 2009.
27. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21: 103-115, 2011.
28. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M. Fibroblast growth factor 23 and inflammation in CKD. Clin J Am Soc Nephrol 7: 1156-1162, 2012.
29. Nadra I, Mason JC, Philippidis P, Florey O, Smythe CD, McCarthy GM, Landis RC, Haskard DO. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ Res 96: 1248-1256, 2005.
30. Navarro-González JF, Mora-Fernádez C, Muros de Fuentes M, Herrera H, Garcia J. Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. Clin J Am Soc Nephrol 4: 1646-1654, 2009.
31. Neven E, Dams G, Postnov A, Chen B, De Clerck N, De Broe ME, D'Haese PC, Persy V. Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats. Nephrol Dial Transplant 24: 1790-1799, 2009.
32. Pazár BP, Ea HK, Narayan S, Kolly L, Bagnoud N, Chobaz V, Roger T, Lioté F, So A, Busso N. Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through the NLRP3 inflammasome in vitro. J Immunol 186: 2495-2502, 2011.
33. Raj DS, Moseley P, Dominic EA, Onime A, Tzamaloukas AH, Boyd A, Shah VO, Glew R, Wolfe R, Ferrando A. Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis. Kidney Int 73: 1054-1061, 2008.
34. Sage AP, Lu J, Tintut Y, Demer LL. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79: 414-422, 2011.
35. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles of calcium and phosphate. Circ Res 109: 697-711, 2011.
36. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88: 1511-1518, 2008.
37. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92, 2003.
38. Shobeiri N, Adams MA, Holden RM. Vascular calcification in animal models of CKD: a review. Am J Nephrol 31: 471-481, 2010.
39. Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y, Takeda E. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 20: 1504-1512, 2009.
40. Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant 27: 1957-1966, 2012.
41. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911, 1999.
42. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15: 953-960, 2000.
43. Son BK, Kozaki K, Iijima K, Eto M, Kojima T, Ota H, Senda Y, Maemura K, Nakano T, Akishita M, Ouchi Y. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Ga6-Axl survival pathway. Circ Res 98: 1024-1031, 2006.
44. Takeda E, Taketani Y, Morita K, Tatsumi S, Katai K, Nii T, Yamamoto H, Miyamoto K. Molecular mechanisms of mammalian inorganic phosphate homeostasis. Adv Enzyme Regul 40: 285-302, 2000.
45. van Bilsen K, van Hagen PM, Bastiaans J, van Meurs JC, Missotten T, Kuijpers RW, Hooijkaas H, Dingjan GM, Baarsma GS, Dik WA. The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-α. Br J Ophthalmol 95: 864-868, 2011.
46. Villa-Bellosta R, Bogaert YE, Levi M, Sorribas V. Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol 27: 1030-1036, 2007.
47. Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS, Rosenblatt KP, Kuro-OM, Lang F. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 123: 812-822, 2013.
48. Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK, Sanderson JE. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20: 1676-1685, 2005.
49. Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H, Iida M, Tsuruya K, Kitazono T. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res 27: 474-485, 2012.
50. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000.
51. Yokozawa T, Zheng PD, Oura H, Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron 44: 230-234, 1986.
52. Zhao G, Xu MJ, Zhao MM, Dai XY, Kong W, Wilson GM, Guan Y, Wang CY, Wang X. Activation of nuclear factor-κB accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int 82: 34-44, 2012.
53. Zhao MM, Xu MJ, Cai Y, Zhao G, Guan Y, Kong W, Tang C, Wang X. Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney Int 79: 1071-1079, 2011.